Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Buckwheat 2S albumin, primarily represented by the major allergen Fag e 2, is a seed storage protein found in common buckwheat (Fagopyrum esculentum) (UniProt P84763). It belongs to the 2S albumin family within the prolamin superfamily and is characterized by a conserved skeleton of eight cysteine residues forming four stabilizing disulfide bonds (PMID: 17910329). Biologically, these proteins serve as essential nutrient reservoirs, providing nitrogen and sulfur to the developing seedling during germination. Clinically, Buckwheat 2S albumin is a potent allergen responsible for severe IgE-mediated hypersensitivity reactions, including life-threatening anaphylaxis (PMID: 16549935). Due to its resistance to heat and gastrointestinal digestion, it remains immunologically active upon ingestion, making it a primary marker for clinical reactivity in buckwheat-allergic patients (PMID: 23978325). In the biotechnology industry, it is a key target for component-resolved diagnostics and the development of allergen-specific immunotherapies (AIT) designed to induce immune tolerance. Therapeutic strategies involve the use of recombinant versions or hypoallergenic derivatives to desensitize the immune system and reduce the risk of accidental allergic episodes (PMID: 32543456).
Induction of immune tolerance and desensitization through repeated exposure to the allergen or its epitopes to shift the immune response from Th2 to Th1/Treg; neutralization of circulating IgE to prevent binding to high-affinity receptors on mast cells and basophils.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Buckwheat 2S albumin (Fag e 2).